On Tuesday, Theravance Inc (NASDAQ:THRX)’s shares declined -4.10% to $6.78.
GlaxoSmithKline plc (GSK) and Theravance, Inc. ( THRX) declared data presented by GSK at the European Respiratory Society (ERS) International Congress (poster PA1001), from an exploratory post-hoc analysis of phase III data, which showed that patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who received Anoro® Ellipta® (UMEC/VI 62.5/25mcg) had a reduced risk of experiencing a clinically important deterioration contrast to tiotropium 18mcg or placebo over a 12-week treatment period.
This post-hoc analysis used a novel, composite endpoint, defined as a clinically important deterioration, to assess the effect of treatment on a number of factors that are each believed to represent a worsening of a patient’s COPD. The analysis examined the time to a first clinically important deterioration which was determined by the occurrence of any of the following events: A decrease in lung function of ≥100 ml from baseline as measured by trough FEV1; a deterioration in health-related quality of life defined as ≥4 unit enhance from baseline in St George’s Respiratory Questionnaire (SGRQ) total score; or the occurrence of an on-treatment moderate-to-severe COPD exacerbation.
Theravance, Inc., a royalty administration company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and VI monotherapy through the Long-Acting Beta2 Agonist partnershipagreement and the planned alliance agreement with Glaxo Group Limited (GSK).
Prologis Inc (NYSE:PLD)’s shares gained 1.89% to $38.74.
Menlo Logistics (Menlo), the US$1.7 billion global logistics and supply chain management subsidiary of Con-way Inc. (CNW), today announced a build-to-suit agreement with global industrial real estate developer Prologis, Inc. (PLD) for a new 70,000-square-meter regional logistics facility in Eindhoven, the Netherlands.
The facility will be located at the Acht industrial park in Eindhoven, adjacent to the A2/N2 Eindhoven ring road, which offers direct access to Belgium and Germany, in addition to Amsterdam to the north. It will be one of the largest build-to-suit projects in the region. The expansion spotlights Menlo’s commitment to investing in the expanding market for high-value warehousing, distribution and fulfillment services in the Benelux region, and its growing prominence as a planned logistics hub for central Europe.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, administration, and leasing of industrial distribution and retail properties.
At the end of Tuesday’s trade, United Parcel Service, Inc. (NYSE:UPS)‘s shares surged 0.91% to $98.16.
The UPS Foundation, the philanthropic arm of UPS (UPS), declared it will award more than $7.9 million to 37 non-profit organizations. These grants will support programs that champion diversity and inclusion by furthering economic empowerment, education, inclusion and mentorship.
As part of its latest charitable contributions, The UPS Foundation extended its partnership with the Paralyzed Veterans of America (PVA) to support its Paving Access to Veterans Employment (PAVE) initiative. The agreement comprises more than $1 million in cash and in-kind support over three years, starting in 2016. Funding provides job search and reintegration resources for paralyzed service members, and support for the annual National Veterans Wheelchair Games and awards dinner.
UPS’s continued dedication to the PVA and its PAVE program reinforces and supplements its own commitment to veterans as the company plans to hire 50,000 veterans by the end of 2018.
United Parcel Service, Inc., a package delivery company, provides transportation, logistics, and financial services in the United States and internationally. It operates in three segments: U.S. Domestic Package, International Package, and Supply Chain & Freight.
Fortinet Inc (NASDAQ:FTNT), ended its Tuesday’s trading session with -1.38% loss, and closed at $42.24.
Fortinet® (FTNT) — the global leader in high-performance cybersecurity solutions — declared that Gary Locke joined Fortinet’s Board of Directors effective September 22, 2015.
Locke is a former Governor of the State of Washington, serving two successive terms, from 1997 to 2005. In addition, from 2009 to 2011, Locke ran the U.S. Department of Commerce as the Commerce Secretary, and he served as the United States Ambassador to China from 2011 until 2014. With more than 20 years of public service leadership, he brings a wealth of experience and knowledge on a broad range of corporate and global issues, related to cybersecurity challenges of different government organizations.
Born and raised in Seattle, Washington, Locke is a graduate of Yale University with a Bachelor of Arts in Political Science and a law degree from Boston University. In addition to his public service, Locke has extensive experience in international law and government relations. Locke’s appointment follows the recent addition of Oracle Chief Marketing Office, Judith Sim to the Fortinet Board of Directors.
Fortinet, Inc. provides cyber security solutions for enterprises, service providers, and government organizations worldwide. The company offers FortiGate physical and virtual appliances products that provide various integrated security and networking functions to protect data, applications, and users from network- and content-level security threats; FortiManager product family to manage the system configuration and security functions of multiple FortiGate devices from a centralized console; and the FortiAnalyzer product family, which enables the collection, analysis, and archiving of content and log data generated by its products. I
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
